An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies https://www.biorxiv.org/content/10.1101/2023.04.20.537738v1?med=mas
An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies https://www.biorxiv.org/content/10.1101/2023.04.20.537738v1?med=mas